Matrine NEW
| Price | $36 | $53 | $74 |
| Package | 25mg | 50mg | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-06-12 |
Product Details
| Product Name: Matrine | CAS No.: 519-02-8 |
| Purity: 97.16% | Supply Ability: 10g |
| Release date: 2025/06/12 |
Product Introduction
Bioactivity
| Name | Matrine |
| Description | Matrine (Vegard), an alkaloid isolated from the Sophora genus, acts as a kappa opioid receptor agonist. |
| In vitro | In human non-small cell lung cancer A549 and hepatocellular carcinoma SMMC-7721 cells, Matrine inhibits cell growth. Particularly, in A549 cells, Matrine induces apoptosis by reducing the Bcl-2 / Bax protein ratio. |
| In vivo | In mice, the median lethal dose (LD50) of Matrine administered via intraperitoneal injection is 157 mg/kg. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | Ethanol : 49 mg/mL (197.29 mM), Sonication is recommended. H2O : 11 mg/mL (44.29 mM), Heating is recommended. DMSO : 45 mg/mL (181.19 mM), Sonication is recommended. |
| Keywords | κ-opioid receptor | OpioidReceptor | Opioid Receptor | Non-small cell lung cancer | Mitophagy | Matrine | hepatoma | Ferroptosis | Autophagy | anti-oxidative stress | a-Matrine | alpha-Matrine | acute kidney injury (AKI) model | A549 cells |
| Inhibitors Related | Stavudine | Cysteamine hydrochloride | Sodium 4-phenylbutyrate | Hydroxychloroquine | Guanidine hydrochloride | L-Glutamic acid | Paeonol | L-Cystine | L-Glutamine | Naringin | Alginic acid | Gefitinib |
| Related Compound Libraries | Pesticide Compound Library | Pain-Related Compound Library | Anti-Neurodegenerative Disease Compound Library | Selected Plant-Sourced Compound Library | Anti-Inflammatory Traditional Chinese Medicine Compound Library | Miao medicine Compound Library | Cosmetic Ingredient Compound Library | Bioactive Compounds Library Max | Heat-Clearing and Detoxifying Traditional Chinese Medicine Compound Library | Ancient Chinese Classical Formulas Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $5.00/1KG |
VIP1Y
|
Wuhan JiyunZen Tech Co., Ltd.
|
2025-05-08 | |
| $/ |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | |
| $0.00/1kg |
VIP1Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-04-27 | |
| $10.00/1KG |
Shandong Xuhuang New material CoLTD
|
2025-02-21 | ||
| $0.00/25KG |
VIP6Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2024-10-11 | |
| $10.00/1KG |
VIP5Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-20 | |
| $0.00/1kg |
VIP3Y
|
Hebei Kingfiner Technology Development Co.Ltd
|
2024-06-11 | |
| $150.00/1kg |
Hebei Zhuanglai Chemical Trading Co.,Ltd
|
2024-04-26 | ||
| $0.00/1Kg |
airuikechemical co., ltd.
|
2024-04-09 | ||
| $0.00/25kg |
Shaanxi Haibo Biotechnology Co., Ltd
|
2023-09-08 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY